Keyphrases
Cell Therapy
69%
T Cells
69%
3D Live Imaging
55%
Cell Behavior
55%
Imaging Platform
55%
Pediatric Cancer Patients
55%
COVID-19 Vaccination
55%
Tumor Response
55%
Behavioral Response
55%
Immune Response
55%
Engineered T Cells
55%
BNT162b2
55%
Cell Tumor
55%
Vaccination
55%
Death Receptor
55%
BCP-ALL
55%
Receptor Expression
55%
Cell-to-cell
55%
CD19 chimeric Antigen Receptor T Cells
55%
Pediatric Tumors
55%
Pediatric Cancer
55%
T Cell Recognition
55%
MR1T
55%
MHC Class I
55%
T Cell Response
41%
Tumor
41%
Cellular Immunotherapy
41%
Human Leukocyte Antigen
41%
Embryonal Tumor
41%
Chimeric Antigen Receptor T-cell Therapy
31%
Chimeric Antigen Receptor T Cells (CAR-T)
31%
Good Responders
27%
Tumor Targeting
27%
Immuno-oncology
27%
Intratumoral Heterogeneity
27%
3D Imaging
27%
Organoids
27%
Immune Cells
27%
Adoptive Cell Therapy
27%
Pediatric Leukemia
27%
T Cell Receptor
27%
Diffuse Midline Glioma
27%
Therapy Strategy
27%
Tumor Protein p53 (TP53)
23%
Relapsed or Refractory
21%
Death Receptor 5
15%
T Cell Cytotoxicity
15%
Fas Receptor
15%
SARS-CoV-2 Spike
13%
BNT162b2 Vaccine
13%
Immunology and Microbiology
T Cell
100%
Cell Function
55%
Immune Response
55%
COVID-19
55%
Immunology
55%
B Cell
55%
Precursor
55%
Chimeric Antigen Receptor T-Cell
55%
Death Receptor
55%
P53
55%
CD19
55%
Immunotherapy
52%
Immunocompetent Cell
41%
Coculture
41%
Chimeric Antigen Receptor T-Cell Therapy
31%
Intravenous Immunoglobulin
27%
Organoid
27%
Spike
22%
Cytotoxicity
15%
Cell Culture
13%
Dynamics
13%
Tumor Cell
13%
Binding Antibody
11%
Blood Level
11%
Antibody Response
11%
Interferon Gamma
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Classification
11%
Expression Analysis
7%
Ectopic Expression
7%
Leukemia Cell Line
7%
Xenograft
7%
Overall Survival
7%
Cell Line
7%
Medicine and Dentistry
Cell Therapy
74%
Death Receptor
55%
Receptor Expression
55%
Precursor
55%
Chimeric Antigen Receptor T-Cell
55%
Acute Lymphoblastic Leukemia
55%
Protein P53
55%
B Cell
55%
Pediatric Cancer
55%
T Cell
55%
Chimeric Antigen Receptor T-Cell Immunotherapy
31%
Human Leukocyte Antigen
27%
Cancer
27%
Tumor
27%
Leukemia
27%
Cytotoxicity
25%
Malignant Neoplasm
18%
Ganglioglioma
18%
T Lymphocyte Receptor
18%
Pediatrics
18%
In Vitro
18%
Immunotherapy
18%
Death Receptor 5
15%
Tumor Necrosis Factor Receptor Superfamily Member 6
15%
Neoplasm
9%
Messenger RNA
9%
Tumor Model
9%
Real-Time Polymerase Chain Reaction
9%
Synapsin I
9%
Survival Rate
9%
RNA Sequence
9%
Mucosal-Associated Invariant T Cell
9%
Intracranial Tumor
9%
Metabolite
9%
Major Histocompatibility Complex
9%
Ectopic Expression
7%
Expression Analysis
7%
Leukemia Cell Line
7%
Xenograft
7%
Cell Line
7%
Treatment Response
7%
Overall Survival
7%